{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:14:09Z","timestamp":1793369649115,"version":"4.5.0"},"reference-count":47,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2021,2,27]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We performed a meta-analysis of observational studies to quantify the magnitude of the association between non-alcoholic fatty liver disease (NAFLD) and risk of extrahepatic cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Scopus and Web of Science databases from the inception date to 30 December 2020 using predefined keywords to identify observational cohort studies conducted in individuals, in which NAFLD was diagnosed by imaging techniques or International Classification of Diseases codes. No studies with biopsy-proven NAFLD were available for the analysis. Meta-analysis was performed using random-effects modelling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 10 cohort studies with 182\u2009202 middle-aged individuals (24.8% with NAFLD) and 8485 incident cases of extrahepatic cancers at different sites over a median follow-up of 5.8 years. NAFLD was significantly associated with a nearly 1.5-fold to twofold increased risk of developing GI cancers (oesophagus, stomach, pancreas or colorectal cancers). Furthermore, NAFLD was associated with an approximately 1.2-fold to 1.5-fold increased risk of developing lung, breast, gynaecological or urinary system cancers. All risks were independent of age, sex, smoking, obesity, diabetes or other potential confounders. The overall heterogeneity for most of the primary pooled analyses was relatively low. Sensitivity analyses did not alter these findings. Funnel plots did not reveal any significant publication bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This large meta-analysis suggests that NAFLD is associated with a moderately increased long-term risk of developing extrahepatic cancers over a median of nearly 6 years (especially GI cancers, breast cancer and gynaecological cancers). Further research is required to decipher the complex link between NAFLD and cancer development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2021-324191","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T13:20:25Z","timestamp":1615209625000},"page":"778-788","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":324,"title":["Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies"],"prefix":"10.1136","volume":"71","author":[{"given":"Alessandro","family":"Mantovani","sequence":"first","affiliation":[{"name":"Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana","family":"Petracca","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Beatrice","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Csermely","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-2579","authenticated-orcid":false,"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[{"name":"Gastroenterology, Hepatology, Endocrinology and Metabolism, Department of Internal Medicine I, Medizinische Universit\u00e4t Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D","family":"Byrne","sequence":"additional","affiliation":[{"name":"Nutrition and Metabolism, Faculty of Medicine, Southampton General Hospital, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"2025120519130510000_71.4.778.1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"2025120519130510000_71.4.778.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.036"},{"key":"2025120519130510000_71.4.778.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"2025120519130510000_71.4.778.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.109"},{"key":"2025120519130510000_71.4.778.5","doi-asserted-by":"crossref","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"2025120519130510000_71.4.778.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27368"},{"key":"2025120519130510000_71.4.778.7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043"},{"key":"2025120519130510000_71.4.778.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.04.034"},{"key":"2025120519130510000_71.4.778.9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322786"},{"key":"2025120519130510000_71.4.778.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0145-7"},{"key":"2025120519130510000_71.4.778.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2018.06.004","article-title":"Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis","volume":"87","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"2025120519130510000_71.4.778.12","first-page":"322","article-title":"Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis","volume":"8","author":"Ding","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2025120519130510000_71.4.778.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2011.02377.x"},{"key":"2025120519130510000_71.4.778.14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2011.237974"},{"key":"2025120519130510000_71.4.778.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-020-01288-6","article-title":"Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2020","journal-title":"Lipids Health Dis"},{"key":"2025120519130510000_71.4.778.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2025120519130510000_71.4.778.17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000142"},{"key":"2025120519130510000_71.4.778.18","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"2025120519130510000_71.4.778.19","doi-asserted-by":"publisher","DOI":"10.2307\/2533446"},{"key":"2025120519130510000_71.4.778.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06816.x"},{"key":"2025120519130510000_71.4.778.21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/codi.12172","article-title":"Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy","volume":"15","author":"Huang","year":"2013","journal-title":"Colorectal Dis"},{"key":"2025120519130510000_71.4.778.22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002080","article-title":"Nonalcoholic cirrhosis increased risk of digestive tract malignancies: a population-based cohort study","volume":"94","author":"Sun","year":"2015","journal-title":"Medicine"},{"key":"2025120519130510000_71.4.778.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182014","article-title":"Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: propensity score matching analysis","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"key":"2025120519130510000_71.4.778.24","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","author":"Kim","year":"2017","journal-title":"J Hepatol"},{"key":"2025120519130510000_71.4.778.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000295"},{"key":"2025120519130510000_71.4.778.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.018"},{"key":"2025120519130510000_71.4.778.27","doi-asserted-by":"crossref","unstructured":"Wang Z , Zhao X , Chen S . Associations between nonalcoholic fatty liver disease and cancers in a large cohort in China. Clin Gastroenterol Hepatol 2020;64.doi:10.1016\/j.cgh.2020.05.009","DOI":"10.1016\/j.cgh.2020.05.009"},{"key":"2025120519130510000_71.4.778.28","article-title":"The association between non-alcoholic fatty liver disease (with or without metabolic syndrome) and extrahepatic cancer development","author":"Yamamoto","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"2025120519130510000_71.4.778.29","article-title":"Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy","author":"Kim","year":"2020","journal-title":"Korean J Intern Med"},{"key":"2025120519130510000_71.4.778.30","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/j.clbc.2020.02.004","article-title":"Association between fatty liver index and risk of breast cancer: a nationwide population-based study","volume":"20","author":"Park","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"2025120519130510000_71.4.778.31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1872-034X.2011.00915.x","article-title":"Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients","volume":"42","author":"Arase","year":"2012","journal-title":"Hepatol Res"},{"key":"2025120519130510000_71.4.778.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201308","article-title":"Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men","volume":"13","author":"Choi","year":"2018","journal-title":"PLoS One"},{"key":"2025120519130510000_71.4.778.33","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-14-0036"},{"key":"2025120519130510000_71.4.778.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226351","article-title":"The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS One"},{"key":"2025120519130510000_71.4.778.35","first-page":"E247","article-title":"Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease","volume":"37 Suppl 1","author":"Kodama","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"2025120519130510000_71.4.778.36","first-page":"242","article-title":"Relationship between non-alcoholic fatty liver disease and breast cancer","volume":"19","author":"Nseir","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"2025120519130510000_71.4.778.37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11739-017-1774-x","article-title":"Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey","volume":"13","author":"Chang","year":"2018","journal-title":"Intern Emerg Med"},{"key":"2025120519130510000_71.4.778.38","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"2025120519130510000_71.4.778.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.013"},{"key":"2025120519130510000_71.4.778.40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322572"},{"key":"2025120519130510000_71.4.778.41","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323082"},{"key":"2025120519130510000_71.4.778.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2734"},{"key":"2025120519130510000_71.4.778.43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3897"},{"key":"2025120519130510000_71.4.778.44","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205"},{"key":"2025120519130510000_71.4.778.45","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9847-0"},{"key":"2025120519130510000_71.4.778.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0198-4"},{"key":"2025120519130510000_71.4.778.47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2021-324191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:13:29Z","timestamp":1764990809000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2021-324191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,7]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/gutjnl-2021-324191"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2021-324191","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}